WASHINGTON, DC—For high-risk patients with in-stent restenosis (ISR), the Agent drug-coated balloon (DCB) maintains an advantage over uncoated balloon angioplasty alone, according to new 3-year follow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results